Huynh, T., Wang, V., Feigin, J., Siegler, E., Kimball, B., Stewart, C., Yun, K., Mai, L., Roman, C. M., Xia, H., Sakemura, R. L., Can, I., Ruiz, O. G., Ogbodo, E., Sirpilla, O., DeFranco, G., Goldberg, S., Saleh, A., Skeele, D., Foote, S., Yamaguchi, Y., Fonkoua, L. K., Torghabeh, M. H., Parikh, S., Pereira, V. C., Buckley, P., Ramsay, A., Shanafelt, T., Kay, N., Kenderian, S. (2025). Ibrutinib enhances 41BB-costimulated CART19 function and persistence through immune reprogramming: Insights from the phase 3 ECOG-ACRIN E1912 clinical Trial. Blood. https://doi.org/10.1182/blood-2025-2101